XTL Biopharmaceuticals Ltd (XTLB) — Long-term Investment Intensity
XTL Biopharmaceuticals Ltd (XTLB) has a Long-term Investment Intensity of 0.2% as of December 2024. Long-term investments of ILA14.00K represent 0.2% of total assets of ILA8.55 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of XTL Biopharmaceuticals Ltd to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
XTL Biopharmaceuticals Ltd Long-term Investment Intensity (2024–2024)
This chart shows how XTL Biopharmaceuticals Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the intensity stands at 0.2%, reflecting long-term investments of ILA14.00K against total assets of ILA8.55 Million ILA. For the complete balance sheet picture, see XTL Biopharmaceuticals Ltd balance sheet assets.
Annual Long-term Investment Intensity for XTL Biopharmaceuticals Ltd (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for XTL Biopharmaceuticals Ltd from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read XTL Biopharmaceuticals Ltd total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.2% | ILA14.00K | ILA8.55 Million | — |